Skip to main content
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.700
0.00 (0.00%)
Apr 29, 2026, 10:30 AM EDT - Market open

Ovid Therapeutics Revenue

In the year 2025, Ovid Therapeutics had annual revenue of $7.25M with 1,181.27% growth. Ovid Therapeutics had revenue of $718.00K in the quarter ending December 31, 2025, with 844.74% growth.

Revenue (ttm)
$7.25M
Revenue Growth
+1,181.27%
P/S Ratio
64.42
Revenue / Employee
$315,304
Employees
23
Market Cap
467.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.25M6.69M1,181.27%
Dec 31, 2024566.00K174.00K44.39%
Dec 31, 2023392.00K-1.11M-73.91%
Dec 31, 20221.50M-206.88M-99.28%
Dec 31, 2021208.38M195.77M1,551.57%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Valneva SE 205.07M
REGENXBIO 170.44M
Ginkgo Bioworks Holdings 170.16M
Assembly Biosciences 72.30M
Entrada Therapeutics 25.42M
Prelude Therapeutics 12.14M
Revenue Rankings

OVID News

More News